Titus Plattel

Titus Plattel is a creative, innovative senior executive who successfully accomplishes breakthrough results in venture-backed/emerging life sciences organizations. As CEO, COO and CBO, he is committed to developing breakthrough novel therapies.

• Extensive business leadership in public (Biogen, Amgen, Bavarian Nordic) and emerging private biotech companies.

• Experience in fundraising, including closing [clinical] partnerships, developing business strategy, budgeting, and planning, building corporate infrastructure and leading operational management.

• Deep expertise in life sciences drug development, program team management, product commercialization, portfolio strategy, corporate and business development.

• Therapeutic area experience in oncology, hematologic malignancies, immunology, dermatology, auto-immune diseases (e.g. T1DM, Psoriasis) and neuro-inflammation.

• Passionate senior executive with results oriented strategic thinking, striving to work with teams to accomplish breakthrough results in a relentless effort to enhance patient care.